RNA Newswire

Comprehensive Real-Time News Feed for RNA.

Results 1 - 20 of 57 in RNA

  1. Research cracks the code that governs infections caused by simple, single-stranded RNA virusesRead the original story w/Photo

    Thursday Feb 26 | PhysOrg Weblog

    A code hidden in the arrangement of the genetic information of single-stranded RNA viruses instructs the virus how to pack itself within its outer shell of proteins. Credit: University of Leeds Researchers, including Dr Robert Coutts, Research Fellow from the School of Life and Medical Sciences, University of Hertfordshire, have cracked a code that governs infections caused by simple, single-stranded RNA viruses similar in many respects to viruses that cause the common cold, polio and the winter vomiting norovirus infections.

    Comment?

  2. Research cracks code governing infections single-stranded RNA virusesRead the original story w/Photo

    Thursday Feb 26 | Science Daily

    Researchers have cracked a code that governs infections caused by simple, single-stranded RNA viruses similar in many respects to viruses that cause the common cold, polio and the winter vomiting norovirus infections. A code hidden in the arrangement of the genetic information of single-stranded RNA viruses instructs the virus how to pack itself within its outer shell of proteins.

    Comment?

  3. Hemispherx Biopharma And To Present New Discoveries Concerning The...Read the original story

    Wednesday Feb 11 | BioSpace

    ... a Specifically Configured dsRNA, to Target Ebola VP35-Induced Disarming of Innate Immune Responses ." Double-stranded RNA (dsRNA) is a common component of viral replication and initiates signaling pathways that normally activate innate immune ...

    Comment?

  4. Ebola: 5 things to knowRead the original story w/Photo

    Tuesday Feb 10 | The San Diego Union-Tribune

    Ebola results from an RNA virus that infects animals such as fruit bats, monkeys, gorillas, chimpanzees - and people. Contact with an infected animal's blood or body fluids is thought to be the original source of the infectious disease.

    Comment?

  5. Hemispherx Biopharma Posts USAMRIID Ebola Study Concluding Ampligen...Read the original story w/Photo

    Monday Feb 9 | Drugs.com

    ... of Ebola." AmpligenA , an experimental therapeutic, is a new class of specifically-configured ribonucleic acid (RNA) compounds targeted as potential treatment of diseases with immunologic defects and/or viral causation. Ebola virus specifically ...

    Comment?

  6. Hemispherx Biopharma: US Army Scientists (USAMRIID) Find Ampligen(R)...Read the original story

    Feb 1, 2015 | BioSpace

    ... treated with placebo had a 100% death rate by Day 7 post-infection. Ebola virus disease appears to be a double-stranded RNA (dsRNA) deficiency disease in which the lethal sequelae stem from the inability of the host (mouse or human) to mount an ...

    Comment?

  7. Case Western researchers awarded NSF grant to develop new method to reduce risk of Ebola virusRead the original story w/Photo

    Jan 27, 2015 | Medical News

    ... test is not being destroyed during processing. The test is designed to detect the presence of Ebola ribonucleic acid, RNA, a key component of the virus' molecular biology. To extract the viral RNA from the tissue for testing, health care workers ...

    Comment?

  8. CWRU researcher on the clock to improve early Ebola detectionRead the original story w/Photo

    Jan 26, 2015 | EurekAlert!

    ... test is not being destroyed during processing. The test is designed to detect the presence of Ebola ribonucleic acid, RNA, a key component of the virus' molecular biology. To extract the viral RNA from the tissue for testing, health care workers ...

    Comment?

  9. Scientists find way to increase length of human telomeresRead the original story w/Photo

    Jan 26, 2015 | Medical News Today

    ... of human cells available for studying. To increase telomere length, the team used a modified type of ribonucleic acid (RNA) that contained the coding sequence of TERT. TERT is the active component of telomerase - an enzyme expressed by stem cells ...

    Comment?

  10. Hemispherx Biopharma Release: Reports Genetic Changes In Ebola Virus...Read the original story

    Jan 25, 2015 | BioSpace

    PHILADELPHIA, Jan. 26, 2015 -- Hemispherx Biopharma, Inc. , announced today that in a new publication in the journal , scientists at the U.S. Army Medical Research Institute of Infectious Disease , Harvard University, and Massachusetts Institute of Technology studied genetic changes in the Ebola virus circulating in West Africa and concluded that genomic drift of the EBOV over time may be sufficient to block the action of otherwise potential therapies that target EBOV genetic sequences. The types of potential drugs at risk include monoclonal antibodies and small-interfering RNA which are scheduled to be evaluated during the current outbreak .

    Comment?

  11. Nanocomplex images differentiating stem cellsRead the original story w/Photo

    Jan 15, 2015 | Nanotechweb.org

    A new technique to image messenger RNA activity in real time has been developed by researchers at the National Institutes of Health in Maryland in the US and Xidian University in Shaanxi, China. The technique, which was used in this work to track how mRNA expresses itself in neuronal stem cells as they differentiate, could help us better understand neurogenesis and perhaps even be used to screen drugs for treating neurodegenerative diseases and brain trauma.

    Comment?

  12. Ebola Virus Mutated From Forest Encroachment, Says Disease SpecialistRead the original story w/Photo

    Jan 13, 2015 | Voice of America

    ... of Ebola into humans." There are other diseases that mutate similarly to Ebola, whose genetic material includes an RNA [ribonucleic acid] virus. Its RNA is single-stranded, which scientists say makes it likely to spread more quickly than other ...

    Comment?

  13. Roche launches next-generation viral load testing assays for new...Read the original story w/Photo

    Dec 8, 2014 | WebWire

    ... selective drug pressure, allowing for more reliable results to confidently and effectively quantify the amount of HIV-1 RNA in a patient's blood. cobas HCV employs Roche's unique dual-probe approach to provide an extra layer of protection against ...

    Comment?

  14. Tekmira Provides Key Highlights Of In New YorkRead the original story

    Nov 23, 2014 | BioSpace

    Tekmira Pharmaceuticals Corporation , a leading developer of RNA interference therapeutics, announced today an update from the Company's Analyst and Investor Day, which took place on November 21 in New York City. The event highlighted Tekmira's key products and clinical development plans, as well as corporate milestones for 2015 and beyond.

    Comment?

  15. Tekmira Provides Key Highlights of Analyst and Investor Day in New YorkRead the original story w/Photo

    Nov 21, 2014 | GlobeNewswire

    Tekmira Pharmaceuticals Corporation , a leading developer of RNA interference therapeutics, announced today an update from the Company's Analyst and Investor Day, which took place on November 21 in New York City. The event highlighted Tekmira's key products and clinical development plans, as well as corporate milestones for 2015 and beyond.

    Comment?

  16. Hemispherx Biopharma Announces Financial Results For The Nine Months Ended September 30, 2014Read the original story

    Nov 10, 2014 | BioSpace

    ... N for Ebola virus. AmpligenA , an experimental therapeutic, is a new class of specifically-configured ribonucleic acid (RNA) compounds targeted as potential treatment of diseases with immunologic defects and/or viral causation. Ebola virus ...

    Comment?

  17. Hemispherx Biopharma And Collaborate On Alferon And Ampligen Against The Ebola VirusRead the original story

    Nov 3, 2014 | BioSpace

    Hemispherx Biopharma, Inc. , has been informed by USAMRIID scientists that they have in-vitro data indicating that AlferonA , the only multi-species, natural alpha interferon commercially approved in the U.S., successfully protected human cells against the Ebola virus. Low concentrations of AmpligenA , an experimental double-stranded RNA therapeutic, also successfully protected human cells against the Ebola virus USAMRIID plans to continue to collect data and to initiate in-vitro synergy studies using AlferonA and AmpligenA .

    Comment?

  18. Scientists capture picture of 'MicroRNA' in actionRead the original story w/Photo

    Nov 3, 2014 | Medical News Today

    ... are snippets of ribonucleic acid, only about 22 nucleotides long. Encoded by genes, they are meant to function as RNA molecules and are never translated into proteins. In humans, there are almost 2,000 distinct microRNAs, which collectively regulate ...

    Comment?

  19. Scripps Research Institute scientists capture picture of 'microRNA' in actionRead the original story w/Photo

    Oct 30, 2014 | Medical News Today

    ... are snippets of ribonucleic acid, only about 22 nucleotides long. Encoded by genes, they are meant to function as RNA molecules and are never translated into proteins. In humans, there are almost 2,000 distinct microRNAs, which collectively regulate ...

    Comment?

  20. Scientists Take Step Towards Drug To Treat...Read the original story w/Photo

    Oct 23, 2014 | RedOrbit

    ... often use a mouse norovirus to identify drugs that can inhibit infection. It is one of a class of viruses known as RNA viruses, which have ribonucleic acid (RNA) as their genetic material. Most of the major viruses that have the potential to become ...

    Comment?